bioMérieux launches its VITEK® MS solution for automated, ultra rapid microorganism identification
11 September 2012 | By bioMérieux
VITEK® MS provides microorganism identification in minutes...
List view / Grid view
11 September 2012 | By bioMérieux
VITEK® MS provides microorganism identification in minutes...
11 September 2012 | By Bristol-Myers Squibb Foundation
Recognizing the increasingly important role nurses play...
11 September 2012 | By Pfizer
WHO has granted an expansion to the prequalification for Prevenar 13...
11 September 2012 | By Peckwater PR
Summit has entered a technology license agreement with Bristol-Myers Squibb Company...
11 September 2012 | By Sanofi Pasteur
“The complexity of dengue virus infection has hampered vaccine research for decades..."
10 September 2012 | By Merck
Merck remains on target to file a New Drug Application with the FDA in 2012...
10 September 2012 | By Boehringer Ingelheim
Boehringer Ingelheim has developed and now implemented a flexible set-up...
10 September 2012 | By Amgen
Amgen announced the appointment of Ray Jordan to the new position of senior vice president, Corporate Affairs...
10 September 2012 | By Biogen Idec
Biogen Idec has sold to a DRI Capital managed fund its royalty and other rights relating to BENLYSTA®...
6 September 2012 | By Eli Lilly and Company
The Phase III POINTBREAK trial did not meet its primary endpoint...
6 September 2012 | By Boehringer Ingelheim
The joint effort will focus on investigating three cell types...
6 September 2012 | By Abbott
Abbott has signed an agreement to collaborate with Astellas Pharma Global Development...
5 September 2012 | By Novartis
New data for Lucentis®...
5 September 2012 | By Roche
Personalised healthcare leadership and world-class pipeline presented at investor conference...
4 September 2012 | By Pfizer
The European Commission has granted marketing authorization for INLYTA® (axitinib)...